Seer (SEER) Operating Expenses (2020 - 2026)
Seer (SEER) posted quarterly Operating Expenses of $18.2 million for Q1 2026, down 19.98% year-over-year from $22.8 million in Q1 2025, and down 6.8% quarter-over-quarter from $19.6 million in Q4 2025.
Seer (SEER) Operating Expenses (2020 - 2026) Analysis & Trends
Seer's Operating Expenses history runs 7 years deep, the most recent figure standing at $18.2 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 19.98% year-over-year to $18.2 million; the TTM figure through Mar 2026 stood at $81.9 million (down 20.79% YoY), while the FY2025 annual figure was $86.5 million, down 19.32% from the prior year.
- Operating Expenses for Q1 2026 stood at $18.2 million, down from $19.6 million in the prior quarter.
- The five-year high for Operating Expenses was $30.2 million in Q2 2023, with the low at $18.2 million in Q1 2026.
- The 5-year median for Operating Expenses is $25.5 million (2024), against an average of $25.2 million.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses surged 51.15% in 2022, then fell 23.3% in 2025.
- Seer's Operating Expenses stood at $27.2 million in 2022, then dropped by 11.05% to $24.2 million in 2023, then rose by 5.28% to $25.5 million in 2024, then dropped by 23.3% to $19.6 million in 2025, then declined by 6.8% to $18.2 million in 2026.
- Business Quant data shows SEER's Operating Expenses at $18.2 million in Q1 2026, $19.6 million in Q4 2025, and $21.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | 18.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.35 Mn |
| Mar 31, 2026 | 18.24 Mn |
| Dec 31, 2025 | 19.57 Mn |
| Sep 30, 2025 | 21.46 Mn |
| Jun 30, 2025 | 22.64 Mn |
| Mar 31, 2025 | 22.79 Mn |
| Dec 31, 2024 | 25.51 Mn |
| Sep 30, 2024 | 26.26 Mn |
| Jun 30, 2024 | 28.83 Mn |
| Mar 31, 2024 | 26.55 Mn |
| Dec 31, 2023 | 24.23 Mn |
| Sep 30, 2023 | 28.00 Mn |
| Jun 30, 2023 | 30.22 Mn |
| Mar 31, 2023 | 29.51 Mn |
| Dec 31, 2022 | 27.24 Mn |
| Sep 30, 2022 | 27.01 Mn |
| Jun 30, 2022 | 25.04 Mn |
| Mar 31, 2022 | 25.03 Mn |
| Dec 31, 2021 | 21.31 Mn |
| Sep 30, 2021 | 19.60 Mn |